AAMS Internal Medicine & Therapeutics · Vol. 7 · Issue 3 · 2026-03-01
SGLT2 Inhibitors and Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction
Williams JD, Kang HW, Abdullayev T
Imperial College London, London, UK; Samsung Medical Center, Seoul, South Korea; Republican Specialized Cardiology Center, Tashkent, Uzbekistan
Abstract
Post-hoc analysis of a large multinational RCT examining the efficacy of SGLT2 inhibitors in 4,800 patients with heart failure with preserved ejection fraction across 18 countries.
Keywords: SGLT2 inhibitors, heart failure, HFpEF, cardiovascular outcomes
Full Text
Post-hoc analysis of a large multinational RCT examining the efficacy of SGLT2 inhibitors in 4,800 patients with heart failure with preserved ejection fraction across 18 countries.
This article is published open access by AAMS Internal Medicine & Therapeutics. The complete peer-reviewed text can be read on the journal page.
Author Citation Metrics
- Williams JD — Citations: 9568 · h-index: 44 · i10-index: 116 · ORCID 0000-0003-2460-9673
- Kang HW — Citations: 0 · h-index: 0 · i10-index: 0
- Abdullayev T — Citations: 95 · h-index: 4 · i10-index: 3
Metrics are sourced from public bibliometric records (OpenAlex) and each author's Google Scholar profile.